Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia

Neurobiology of Aging

Volumn 32, Issue 1, 2011, Pages 31-41

  Tong, Zhiqian ^a   Zhang, Jinling ^a   Luo, Wenhong ^b   Wang, Weishan ^c   Li, Fangxu ^a   Li, Hui ^b   Luo, Hongjun ^b   Lu, Jing ^a   Zhou, Jiangning ^e   Wan, You ^f   He, Rongqiao ^a,d  

^a INSTITUTE OF BIOPHYSICS   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c Dept of Psychol Rehabilitation   (China)

^d INSTITUTE OF PSYCHOLOGY   (China)

^e UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^f PEKING UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Formaldehyde; Mini mental state examination (MMSE) scores; One carbon cycle; Senile dementia; Urine

Indexed keywords

AMYLOID BETA PROTEIN; FORMALDEHYDE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SENILE DEMENTIA; TRANSGENIC MOUSE; URINALYSIS; URINE LEVEL;

AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANGIOTENSIN AMIDE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; FEMALE; FORMALDEHYDE; HIPPOCAMPUS; HUMANS; MALE; MAZE LEARNING; MEMORY DISORDERS; MENTAL STATUS SCHEDULE; MICE; MICE, TRANSGENIC; NEUROPSYCHOLOGICAL TESTS; PRESENILIN-1; STATISTICS AS TOPIC;

EID: 78449301205     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.07.013     Document Type: Article

References (54)

1. Andres N., Lizcano J.M., Rodriguez M.J., Romera M., Unzeta M., Mahy N. Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. Journal of Histochemistry and Cytochemistry 2001, 49:209-218.
2. Banks W.A., Farr S.A., Morley J.E., Wolf K.M., Geylis V., Steinitz M. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Experimental Neurology 2007, 206:248-256.
3. Barker S.A., Carl G.F., Monti J.A. Hyperformaldehydism: a unifying hypothesis for the major biochemical theories of schizophrenia. Medical Hypotheses 1980, 6:671-686.
4. Bhatt H.V., Panchal G.M. Behavioural change in rats due to chronic oral and systemic formaldehyde. Indian Journal of Physiology and Pharmacology 1992, 36:270-272.
5. Butcher J. Urine tests for Alzheimer's disease-are they fool's gold?. Lancet Neurology 2007, 6:106-107.
6. Chen K., Maley J., Yu P.H. Potential implications of endogenous aldehydes in [beta]-amyloid misfolding, oligomerization and fibrillogenesis. Journal of Neurochemistry 2006, 99:1413.
7. Corey-Bloom J., Thal L.J., Galasko D., Folstein M., Drachman D., Raskind M., Lanska D.J. Diagnosis and evaluation of dementia. Neurology 1995, 45:211-218.
8. Cui Xiangli Inhaled formaldehyde on the effects of GSH level and distribution of formaldehyde. China Journal of Preventive Medicine 1996, 30:186.
9. Estonius M., Svensson S., Höög J.O. Alcohol dehydrogenase in human tissues: localisation of transcripts coding for five classes of the enzyme. FEBS Letters 1996, 397:338-342.
10. Ferrer I., Lizcano J.M., Hernández M., Unzeta M. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neuroscience Letters 2002, 321:21-24.
11. Floor E., Maples A.M., Rankin C.A., Yaganti V.M., Shank S.S., Nichols G.S., O'Laughlin M., Galeva N.A., Williams T.D. A one-carbon modification of protein lysine associated with elevated oxidative stress in human substantia nigra. Journal of Neurochemistry 2006, 97:504.
12. Ghanbari H., Ghanbari K., Beheshti I., Munzar M., Vasauskas A., Averback P. Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker. Journal of Clinical Laboratory Analysis 1998, 12:285-288.
13. Gurel A., Coskun O., Armutcu F., Kanter M., Ozen O.A. Vitamin E against oxidative damage caused by formaldehyde in frontal cortex and hippocampus: biochemical and histological studies. Journal of Chemical Neuroanatomy 2005, 29:173-178.
14. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
15. Head E., Pop V., Vasilevko V., Hill M, Saing T., Sarsoza F., Nistor M., Christie L.A., Milton S., Glabe C., Barrett E., Cribbs D. A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta. Journal of Neuroscience 2008, 28:3555-3566.
16. Heck H., White E.L., Casanova-Schmitz M. Determination of formaldehyde in biological tissues by gas chromatography/mass spectrometry. Biomedical Mass Spectrometry 1982, 9:347-353.
17. Holmes C., Boche D., Wilkinson D., Yadegarfar G., Hopkins V., Bayer A., Jones R.W., Bullock R., Love S., Neal J.W., Zotova E., Nicoll J.A. Long-term effects of abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008, 372:216-223.
18. Jellinger K.A., Janetzky B., Attems J., Kienzl E. Biomarkers for early diagnosis of Alzheimer disease: Alzheimer associated gene-a new blood biomarker?. Journal of Cellular and Molecular Medicine 2008, 12:1094-1117.
19. Kalász H. Biological role of formaldehyde, and cycles related to methylation, demethylation, and formaldehyde production. Mini Reviews in Medicinal Chemistry 2003, 3:175-192.
20. Kamino K., Nagasaka K., Imagawa M., Yamamoto H., Yoneda H., Ueki A., Kitamura S., Namekata K., Miki T., Ohta S. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochemical and Biophysical Research Communications 2000, 273:192-196.
21. Kang J.E., Cirrito J.R., Dong H., Csernansky J.G., Holtzman D.M. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10673-10678.
22. Karuppagounder, S.S., Pinto, J.T., Xu, H., Chen, H.L., Beal, M.F., Gibson, G.E., 2008. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochemistry International (Epub ahead of print).
23. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid {beta} protein in the Tg2576 transgenic mouse model of Alzheimer's disease. Journal of Neuroscience 2001, 21:10.
24. Khokhlov A.P., Zavalishin I.A., Savchenko I.N., Dziuba A.N. Disorders of formaldehyde metabolism and its metabolic precursors in patients with multiple sclerosis. Zhurnal nevrologii i psikhiatrii imeni S. S. Korsakova 1989, 89:45-48.
25. Kilburn K.H., Warshaw R., Thornton J.C. Formaldehyde impairs memory, equilibrium, and dexterity in histology technicians: effects which persist for days after exposure. Archives of Environmental Health 1987, 42:117-120.
26. Kuo H., Ingram D.K., Walker L.C., Tian M., Hengemihle J.M., Jucker M. Similarities in the age-related hippocampal deposition of periodic acid-Schiff-positive granules in the senescence-accelerated mouse (SAM P8) and C57BL/6 mouse strains. Neuroscience 1996, 74:733-740.
27. Lee E.S., Chen H., Hardman C., Simm A., Charlton C. Excessive S-adenosyl-l-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: Possible role in S-adenosyl-l-methionine-induced Parkinson's disease-like disorders. Life Sciences 2008, 83:821-827.
28. Luo W., Li H., Zhang Y., Ang C.Y.W. Determination of formaldehyde in blood plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B: Biomedical Sciences and Applications 2001, 753:253-257.
29. Lyles G.A. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. International Journal of Biochemistry and Cell Biology 1996, 28:259-274.
30. Marceaux J.C., Dilks L.S., Hixson S. Neuropsychological effects of formaldehyde use. Journal of Psychoactive Drugs 2008, 40:207-210.
31. Martinez F., Flores C., de las Heras P., Lekumberri M., Menocal G., Imirizaldu Z., Jose J. Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain). BMC Neurology 2008, 8:39.
32. McKhann, G., 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, vol. 34. AAN Enterprises, pp. 939-944.
33. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 1984, 11:47-60.
34. Nie C.L., Wang X.S., Liu Y., Perrett S., He R.Q. Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells. BMC Neuroscience 2007, 8:9.
35. Nie C.L., Wei Y., Chen X., Liu Y.Y., Dui W., Liu Y., Davies M.C., Tendler S.J.B., He R.G. Formaldehyde at low concentration induces protein tau into globular amyloid-like aggregates in vitro and in vivo. PLoS ONE 2007, 2.
36. Onozuka M., Watanabe K., Fujita M., Tomida M., Ozono S. Changes in the septohippocampal cholinergic system following removal of molar teeth in the aged SAMP8 mouse. Behavioural Brain Research 2002, 133:197-204.
37. Pasquier F. Early diagnosis of dementia: neuropsychology. Journal of Neurology 1999, 246:6-15.
38. Perna R.B., Bordini E.J., Deinzer-Lifrak M. A case of claimed persistent neuropsychological sequelae of chronic formaldehyde exposure clinical, psychometric, and functional findings. Archives of Clinical Neuropsychology 2001, 16:33-44.
39. Retfalvi T., Nemeth Z.I., Sarudi I., Albert L. Alteration of endogenous formaldehyde level following mercury accumulation in different pig tissues. Acta Biologica Hungarica 1998, 49:375-379.
40. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurology 2006, 5:949-960.
41. Rocha-González H.I., Ambriz-Tututi M., Granados-Soto V. Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases. CNS Neuroscience Therapy 2008, 14:234-247.
42. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutation Research-Reviews in Mutation Research 2008, 658:68-94.
43. Shcherbakova L.N., Tel'pukhov V.I., Trenin S.O., Bashilov I.A., Lapkina T.I. Permeability of the blood-brain barrier to intra-arterial formaldehyde. Biulleten' eksperimental'noi biologii i meditsiny 1986, 102:573-575.
44. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., Casero R.A. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
45. Spanel P., Smith D., Holland T.A., Singary W.A., Elder J.B. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid Communications in Mass Spectrometry 1999, 13:1354-1359.
46. Stumpf D.A. The neurology of folate and vitamin B12 1997, Northwestern University.
47. Szende B., Király-Véghely Z., Kátay G., Németh Z.I., Albert L., Tyihák E. Formaldehyde cycle and the natural formaldehyde generators and capturers. Acta Biologica Hungarica 1998, 49:225.
48. Taranenko N.A., Efimova N.V. Biomonitoring of formaldehyde in the urinary samples from the pediatric population in the Irkutsk region. Gigiena i Sanitariia 2007, 4:73-75.
49. Teng S., Beard K., Pourahmad J., Moridani M., Easson E., Poon R., O'Brien P.J. The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chemico-Biological Interactions 2001, 130:285-296.
50. Tombaugh T.N., McIntyre N.J. The Mini-Mental State Examination: a comprehensive review. Journal of the American Geriatrics Society 1992, 40:922-935.
51. Tong Z.Q., Wan Y., Luo W.H., Rongq He. Endogenous formaldehyde and some important human diseases. Progress of Natural science 2008, 11:1201-1210.
52. Trinchese F., Liu S., Battaglia F., Walter S., Mathews P.M., Arancio O. Progressive age-related development of Alzheimer-like pathology in APP/PS 1 mice. Annals of Neurology 2004, 55:801-814.
53. Yang X.Q. Epidemiological features of senile dementia and its prevention. Occupational Health 2008, 24:2.
54. Yu P.H., Lai C.T., Zuo D.M. Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochemical Research 1997, 22:615-620.